STOCK TITAN
  1. Home
  2. Sec-filings
  3. SYNA
  4. [144] SYNAPTICS Inc SEC Filing

Synaptics (SYNA) insider plans 450-share common stock sale under Form 144

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Synaptics, Inc. is registering a proposed sale of 450 shares of common stock by an affiliated seller through Morgan Stanley Smith Barney LLC Executive Financial Services, referencing an expected sale date of July 20, 2026 on NASDAQ. The filing notes these securities relate to Restricted Stock Units dated July 17, 2026. It also lists prior sales under a Rule 10b5-1 trading plan for Lisa Bodensteiner, including transactions of 334 shares on June 18, 2026 and 612 shares on May 19, 2026.

Positive

  • None.

Negative

  • None.
Shares to be sold 450 shares Common stock proposed for sale on or about July 20, 2026
Aggregate market value $51,320.25 Value associated with 450 shares of common stock
Shares outstanding 38,637,685 shares Common shares outstanding for Synaptics, Inc.
Prior sale May 19, 2026 612 shares Common stock sold under a Rule 10b5-1 plan
Prior sale June 18, 2026 334 shares Common stock sold under a Rule 10b5-1 plan
Proceeds May 19, 2026 sale $70,275.96 Dollar amount listed for 612-share 10b5-1 sale
Proceeds June 18, 2026 sale $46,185.52 Dollar amount listed for 334-share 10b5-1 sale
Form 144 regulatory
"Filer Information | | | 144: Filer Information"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
Restricted Stock Units financial
"Common | 07/17/2026 | Restricted Stock Units | Issuer"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
10b5-1 Sales regulatory
"10b5-1 Sales for LISA BODENSTEINER 1109 McKay Drive"
10b5-1 sales are pre-arranged stock-trading plans that let company insiders automatically buy or sell shares according to a fixed schedule or formula, even if they later learn confidential information. Think of it as setting up an automatic thermostat for trades: it creates a clear, documented path that can protect insiders from insider-trading accusations and gives investors a signal about predictable insider activity—though it can also simply be a way for insiders to diversify or raise cash.
Executive Financial Services financial
"Morgan Stanley Smith Barney LLC Executive Financial Services 1"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

FAQ

What does Synaptics (SYNA) report in this Form 144 filing?
Synaptics reports a proposed sale of 450 shares of common stock related to Restricted Stock Units, expected to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services on July 20, 2026 on NASDAQ.

How many Synaptics (SYNA) shares are proposed to be sold under this notice?
The notice covers a proposed sale of 450 shares of Synaptics common stock. These shares are associated with Restricted Stock Units dated July 17, 2026 and are expected to be sold on NASDAQ through Morgan Stanley Smith Barney LLC.

What prior 10b5-1 sales are disclosed for Synaptics (SYNA) insider Lisa Bodensteiner?
The filing lists two prior Rule 10b5-1 sales for Lisa Bodensteiner: 612 shares of common stock on May 19, 2026 and 334 shares on June 18, 2026, with stated dollar amounts for each transaction.

What aggregate market value is associated with the Synaptics (SYNA) shares to be sold?
The proposed 450-share sale of Synaptics common stock is associated with an aggregate market value of $51,320.25, as stated in the filing, in connection with trading on NASDAQ.

How many Synaptics (SYNA) shares are reported as outstanding in this filing?
The filing cites 38,637,685 shares of Synaptics common stock as outstanding. This figure is presented for context regarding the issuer’s total outstanding shares and is separate from the 450 shares proposed for sale.

What type of security is being sold in this Synaptics (SYNA) Form 144?
The security is common stock, originating from Restricted Stock Units dated July 17, 2026. The planned sale of 450 shares is to occur on NASDAQ through Morgan Stanley Smith Barney LLC Executive Financial Services.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Source: View Original Filing on SEC EDGAR